Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

PGD2 stops hair growth and is higher in bald men with AGA.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.